$CFR Cashflow Statement | Understand Stock

$CFR

$158.58 +$1.53 (0.97%) Close

$CFR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating Activities:
Net income (loss)
Adjustments to reconcile net income to net cash from operating activities:
Credit loss expense
Deferred tax expense (benefit)
Accretion of loan discounts
Securities premium amortization (discount accretion), net
Net (gain) loss on securities transactions
Depreciation and amortization
Net (gain) loss on sale/exchange/write-down of assets/foreclosed assets
Stock-based compensation
Net tax benefit from stock-based compensation
Earnings on life insurance policies
Net change in:
Trading account securities
Lease right-of-use assets
Accrued interest receivable and other assets
Accrued interest payable and other liabilities
Net cash provided by (used in) operating activities
Investing Activities:
Securities held to maturity: Purchases
Securities held to maturity: Maturities, calls and principal repayments
Securities available for sale:
Purchases
Sales
Maturities, calls and principal repayments
Proceeds from sale of loans
Net change in loans
Net cash paid in insurance agency asset acquisitions
Benefits received on life insurance policies
Proceeds from sales of premises and equipment
Purchases of premises and equipment
Proceeds from sales of repossessed properties
Net cash provided by (used in) investing activities
Financing Activities:
Net change in deposits
Net change in short-term borrowings
Proceeds from Federal Home Loan Bank advances
Principal payments on Federal Home Loan Bank advances
Principal payments on long-term borrowings
Redemption of Series A preferred stock
Proceeds from issuance of Series B preferred stock
Proceeds from stock option exercises
Purchase of treasury stock
Cash dividends paid on preferred stock
Cash dividends paid on common stock
Net cash provided by (used in) financing activities
Net change in cash and cash equivalents

Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year

Comments